NOVOCURE LTD

NASDAQ: NVCR (NovoCure Limited)

Last update: 3 days ago, 12:18AM

20.18

0.92 (4.78%)

Previous Close 19.26
Open 19.39
Volume 890,982
Avg. Volume (3M) 1,002,891
Market Cap 2,218,084,608
Price / Sales 3.59
Price / Book 6.16
52 Weeks Range
11.70 (-42%) — 34.13 (69%)
Earnings Date 27 Feb 2025
Profit Margin -27.86%
Operating Margin (TTM) -38.66%
Diluted EPS (TTM) -1.56
Quarterly Revenue Growth (YOY) 20.50%
Total Debt/Equity (MRQ) 189.72%
Current Ratio (MRQ) 1.46
Operating Cash Flow (TTM) -26.37 M
Levered Free Cash Flow (TTM) 9.29 M
Return on Assets (TTM) -8.77%
Return on Equity (TTM) -46.67%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock NovoCure Limited Mixed Bullish

AIStockmoo Score

0.3
Analyst Consensus 4.0
Insider Activity 0.0
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators -0.5
Average 0.30

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
NVCR 2 B - - 6.16
MASI 10 B - - 9.55
BRKR 7 B 0.42% 63.42 3.95
LIVN 2 B - 35.95 1.61
ATEC 2 B - - 50.98
INMD 1 B - 8.45 1.88

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Sector Healthcare
Industry Medical Devices
Investment Style Small Core
% Held by Insiders 9.46%
% Held by Institutions 84.82%
52 Weeks Range
11.70 (-42%) — 34.13 (69%)
Price Target Range
38.00 (88%) — 42.00 (108%)
High 42.00 (Piper Sandler, 108.13%) Buy
Median 40.00 (98.22%)
Low 38.00 (HC Wainwright & Co., 88.31%) Buy
Average 40.00 (98.22%)
Total 2 Buy
Avg. Price @ Call 29.82
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 14 Jan 2025 38.00 (88.31%) Buy 26.23
Piper Sandler 13 Dec 2024 42.00 (108.13%) Buy 33.41
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BEN ARYE BARAK 18.19 - 54,975 999,995
BRACKMANN CHRISTOPH 18.19 - 54,975 999,995
CORDOVA ASHLEY 18.19 18.90 135,634 2,453,072
LEONARD FRANK X 18.19 18.90 37,412 664,774
LEUPIN NICOLAS 18.19 19.23 53,984 980,938
PARAVASTHU MUKUND 18.19 18.90 52,711 956,722
PURI MICHAL NATH 18.19 19.23 53,588 973,323
WEINBERG URI 18.19 18.74 50,070 906,634
Aggregate Net Quantity 493,349
Aggregate Net Value ($) 8,935,454
Aggregate Avg. Buy ($) 18.19
Aggregate Avg. Sell ($) 18.93
Insider Range ($)
18.19 (-9%) — 19.23 (-4%)
Name Holder Date Type Quantity Price Value ($)
PURI MICHAL NATH Officer 04 Mar 2025 Acquired (+) 54,975 18.19 999,995
BEN ARYE BARAK Officer 04 Mar 2025 Acquired (+) 54,975 18.19 999,995
WEINBERG URI Officer 04 Mar 2025 Acquired (+) 54,975 18.19 999,995
LEONARD FRANK X Officer 04 Mar 2025 Acquired (+) 54,975 18.19 999,995
PARAVASTHU MUKUND Officer 04 Mar 2025 Acquired (+) 54,975 18.19 999,995
CORDOVA ASHLEY Officer 04 Mar 2025 Acquired (+) 151,181 18.19 2,749,982
LEUPIN NICOLAS Officer 04 Mar 2025 Acquired (+) 54,975 18.19 999,995
BRACKMANN CHRISTOPH Officer 04 Mar 2025 Acquired (+) 54,975 18.19 999,995
PARAVASTHU MUKUND Officer 03 Mar 2025 Sell (-) 250 18.41 4,603
CORDOVA ASHLEY Officer 03 Mar 2025 Sell (-) 2,053 18.41 37,796
LEONARD FRANK X Officer 03 Mar 2025 Sell (-) 2,527 18.41 46,522
WEINBERG URI Officer 03 Mar 2025 Sell (-) 268 18.41 4,934
PARAVASTHU MUKUND Officer 28 Feb 2025 Sell (-) 368 19.07 7,018
CORDOVA ASHLEY Officer 28 Feb 2025 Sell (-) 2,341 19.07 44,643
LEONARD FRANK X Officer 28 Feb 2025 Sell (-) 2,770 19.07 52,824
WEINBERG URI Officer 28 Feb 2025 Sell (-) 4,637 19.07 88,428
PARAVASTHU MUKUND Officer 27 Feb 2025 Sell (-) 1,646 19.23 31,653
CORDOVA ASHLEY Officer 27 Feb 2025 Sell (-) 11,153 19.23 214,472
LEONARD FRANK X Officer 27 Feb 2025 Sell (-) 12,266 19.23 235,875
PURI MICHAL NATH Officer 27 Feb 2025 Sell (-) 1,387 19.23 26,672
LEUPIN NICOLAS Officer 27 Feb 2025 Sell (-) 991 19.23 19,057
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria